ATE307596T1 - Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe - Google Patents

Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe

Info

Publication number
ATE307596T1
ATE307596T1 AT98932096T AT98932096T ATE307596T1 AT E307596 T1 ATE307596 T1 AT E307596T1 AT 98932096 T AT98932096 T AT 98932096T AT 98932096 T AT98932096 T AT 98932096T AT E307596 T1 ATE307596 T1 AT E307596T1
Authority
AT
Austria
Prior art keywords
oligosaccharide
blood clotting
extracorporal
circuits
prevent blood
Prior art date
Application number
AT98932096T
Other languages
English (en)
Inventor
Jean Marc Herbert
Jacobus Christianus J Stiekema
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE307596T1 publication Critical patent/ATE307596T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT98932096T 1997-05-27 1998-05-22 Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe ATE307596T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201586 1997-05-27
PCT/EP1998/003174 WO1998053829A1 (en) 1997-05-27 1998-05-22 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits

Publications (1)

Publication Number Publication Date
ATE307596T1 true ATE307596T1 (de) 2005-11-15

Family

ID=8228366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98932096T ATE307596T1 (de) 1997-05-27 1998-05-22 Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe

Country Status (12)

Country Link
US (3) US6391339B1 (de)
EP (2) EP1593380A3 (de)
JP (2) JP2002503270A (de)
AT (1) ATE307596T1 (de)
AU (1) AU8211398A (de)
BR (1) BR9809478A (de)
CA (1) CA2289522A1 (de)
DE (1) DE69832066T2 (de)
DK (1) DK0984785T3 (de)
ES (1) ES2251090T3 (de)
NO (1) NO325142B1 (de)
WO (1) WO1998053829A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8211398A (en) * 1997-05-27 1998-12-30 Akzo Nobel N.V. Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
FR2804328B1 (fr) 2000-01-27 2002-03-15 Hospal Ind Membrane semi-permeable non thrombogene et procede de fabrication
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
ES2861359T3 (es) * 2009-12-01 2021-10-06 Exthera Medical Corp Dispositivo para eliminar citoquinas de la sangre con polisacáridos inmovilizados en superficie
EP2861273B1 (de) 2012-06-13 2017-08-23 ExThera Medical Corporation Verwendung von heparin und kohlenhydraten zur behandlung von krebs
BR112016009827B1 (pt) 2013-11-08 2021-10-26 Exthera Medical Corporation Método in vitro para concentrar patógenos infecciosos presentes em uma amostra biológica obtida a partir de um indivíduo sob suspeita de estar infectado com os ditos patógenos, concentrador e kit
EP3134146B1 (de) 2014-04-24 2024-12-25 ExThera Medical Corporation Verfahren zur entfernung von bakterien aus blut unter verwendung einer hohen durchflussrate
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
WO2020231830A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
DE3008993A1 (de) * 1980-03-08 1981-10-01 Röhm Pharma GmbH, 6100 Darmstadt Pharmazeutische zubereitungen
US4331697A (en) * 1980-09-02 1982-05-25 Teijin Limited Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
US4987223A (en) * 1981-12-23 1991-01-22 Choay S.A. Derivatives of the uronic acid
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
US4801583A (en) * 1982-01-15 1989-01-31 Choay S.A. Oligosaccharides and their biological applications
JPS63218691A (ja) * 1987-03-09 1988-09-12 Rikagaku Kenkyusho 新規な５糖類化合物及びその製造法並びに抗凝血及び抗血栓剤
EP0300099A1 (de) * 1987-07-20 1989-01-25 Akzo N.V. Pentasaccharide
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US5252213A (en) * 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
WO1993005825A1 (en) * 1991-09-20 1993-04-01 Baxter International Inc. Processes for reducing the thrombogenicity of biomaterials
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US6391369B1 (en) * 1996-03-27 2002-05-21 Bunge Foods Corporation Selectively hydrogenated high oleic oil compositions and process
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
AU8211398A (en) * 1997-05-27 1998-12-30 Akzo Nobel N.V. Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits

Also Published As

Publication number Publication date
BR9809478A (pt) 2000-06-20
DK0984785T3 (da) 2006-01-30
EP1593380A3 (de) 2008-06-11
AU8211398A (en) 1998-12-30
NO995800L (no) 1999-11-26
EP0984785B1 (de) 2005-10-26
US20070197637A1 (en) 2007-08-23
CA2289522A1 (en) 1998-12-03
EP1593380A2 (de) 2005-11-09
US20020040012A1 (en) 2002-04-04
JP2002503270A (ja) 2002-01-29
NO995800D0 (no) 1999-11-26
DE69832066T2 (de) 2006-07-13
WO1998053829A1 (en) 1998-12-03
EP0984785A1 (de) 2000-03-15
JP2010013455A (ja) 2010-01-21
NO325142B1 (no) 2008-02-11
DE69832066D1 (de) 2005-12-01
ES2251090T3 (es) 2006-04-16
US6391339B1 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
DE60120761D1 (de) Hämodiafiltration/hämofiltrations-patronen
KR890011606A (ko) 항응고제
DE68913557D1 (de) Peritonealdialyse-katheter.
ATE425139T1 (de) Benzamidinderivate
ES2120132T3 (es) Aductos de bisulfito de argininaldehidos utiles como inhibidores de la trombina y anticoagulantes.
DE69005347D1 (de) Absaugkanüle für chirurgische Zwecke, insbesondere für Fettabsaugung.
DE69206465D1 (de) Peritonealdialyse-Katheter.
WO2001037894A3 (en) Fluid replacement systems and methods for use in hemofiltration
BR9916111A (pt) Derivados de fenilglicina
ATE307596T1 (de) Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe
DK0456806T3 (da) Histidinforpufret peritonealdialyseopløsning
NZ507835A (en) Heterocyclic derivatives which inhibit factor XA
DK261490D0 (da) New pharmaceutical compound
DK0824698T3 (da) Anordning og fremgangsmåde til biospecifik fjernelse af heparin
ATE316384T1 (de) Neue dialysemethode
FR2672487B1 (fr) Filtre veineux autocentrant modulable implantable sur le trajet sanguin.
IT8722399A0 (it) Metodo per prevenire la formazionedi coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso.
CY1111509T1 (el) Ενωσεις με ιδιοτητες απελευθερωσης αυξητικης ορμονης
ITMI20020526A1 (it) Serbatoio di sangue venoso in circuito extracorporeo
ES2085462T3 (es) Combinacion anticoagulante de laci y de polisacaridos sulfatados.
ATE13489T1 (de) Thrombininhibitor, seine herstellung und verwendung.
ITTO930757A0 (it) Macchina per dialisi extracorporea.
DE10084241D2 (de) Heparin mit mittlerer Molmasse
DK0570356T3 (da) Reagens til bestemmelse af den aktiverede partielle thromboplastintid (APTT)
ATE360437T1 (de) Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie a

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0984785

Country of ref document: EP